ライフサイエンスコーパス: VR

1 VR did not affect EDD in young mice.

2 VR increased endothelial NO synthase (eNOS) protein expr

3 VR inhibits H115W HuPON1 competitively when paraoxon is

4 VR rates were higher in arms A-D than in arm E at weeks

5 VR simulation training offers a powerful and effective p

6 VR surgical planning was performed on virtual models.

7 VR training was more efficient than box training (transf

8 VR training, however, is the more efficient training mod

9 VR was defined as attaining plasma HIV-1 RNA levels belo

10 VR-CAP was more effective than R-CHOP in patients with n

11 VR-I differences modify the raised region of the capsid

12 VR-PAH and VN-PAH can be differentiated with the use of

13 VR-SIM confirmed detection of positive surgical margins

14 In the safety population (100 R-CHOP and 101 VR-CHOP patients), grade >/= 3 adverse events included n

15 -up of 34 months, with 25% (R-CHOP) and 18% (VR-CHOP) of patients having had PFS events, the hazard r

16 lity Questionnaire for Children (CVAQC), (2) VR QoL with the Impact of Vision Impairment for Children

17 b 1.3 mg/m(2) intravenously on days 1 and 4 (VR-CHOP).

18 These trees correctly identified 5 of 5 VR-PAH patients in the validation cohort.

19 e or more doses of study drug (91 R-CHOP, 92 VR-CHOP).

20 A VR by week 2 or 4 had the highest positive PV for SVR24

21 Training on either a VR simulator or on a box trainer significantly decreased

22 We implemented a VR setup for rats, including software and large-scale el

23 ve and life-like sculpture of a human into a VR simulation, greater utilitarian actions continued to

24 The main outcome measure was the PV of a VR (HCV RNA <50 IU/mL) by weeks 2, 4, and 12 of treatmen

25 The absence of a VR by week 12 had the highest negative PV across all gen

26 All subjects were required to train on a VR simulation curriculum for the same duration and skill

27 m of deliberate individualized practice on a VR simulator improves technical performance in the OR.

28 ovement was stable both over time and across VR environments.

29 n human renal transplant patients with acute VR (n = 16) compared to ATIR (n = 16) and normal graft f

30 LG3 are increased in association with acute VR of renal allografts and to evaluate the impact of LG3

31 In patients with acute VR, graft loss was associated with elevated LG3 levels.

32 n human renal transplant patients with acute VR, tubulo-interstitial rejection (ATIR) and normal graf

33 In addition, VR led to lower preoperative VAS stress score (differenc

34 tinomial logistic regressions using adequate VR for low U5MR countries and verbal autopsy data for hi

35 was 84.3 (standard deviation, SD, 6.4) after VR, and 64.3 (SD, 11.7) after standard preoperative expe

36 The nerve agent VR yielded no aged adduct, supporting crystal structure

37 MARC-145 cells by PRRSV strains VR-2332 and VR-2385 also resulted in KPNA1 reduction, whereas infect

38 2E6, modest activity with phenyl acetate and VR, and enhanced VX hydrolysis.

39 ity 3D models directly compatible for AR and VR applications.

40 the development and accessibility of AR and VR contents for bioinformatics and cheminformatics appli

41 preparing 3D models ready to use for AR and VR is time-consuming and requires a technical expertise

42 AR and VR technologies allow for stunning and immersive experie

43 Overall response rate with R-CHOP and VR-CHOP was 98% and 96%, respectively.

44 ANMEL) using 3,3'-diaminobenzidine (DAB) and VR.

45 racterized from 0.100-50.0 ng/mL for GB- and VR-Tyr and 0.250-50.0 ng/mL for GA-, GD-, GF-, and VX/VM

46 to AAV4, but at only three (VR-I, VR-II, and VR-IV) compared to AAV2 and AAV8.

47 assembly and genome packaging, and VR-IV and VR-VII are associated with transduction and antigenic di

48 AV surface variable regions (VRs), VR-IV and VR-VII.

49 AV capsid assembly and genome packaging, and VR-IV and VR-VII are associated with transduction and an

50 cost-effective option for all programs, and VR training was more cost-effective for programs with mo

51 y 2-s-long hippocampal motifs in both RW and VR that had similar structure, including phase precessio

52 IR (as a continuous predictor over time) and VR (as a time-varying predictor) and the relation betwee

53 Binocular visual function (VF and VA) and VR QOL.

54 The V-type nerve agents (VX and VR) are among the most toxic substances known.

55 lyzing the hydrolysis of nerve agents VX and VR.

56 sphoryl centers found in GB, GD, GF, VX, and VR has been developed.

57 hromophoric analogues of GB, GD, GF, VX, and VR have been improved up to 15000-fold relative to that

58 erve agent analogues for GB, GD, GF, VX, and VR than the less toxic R(P)-enantiomers.

59 most well-known are GA, GB, GD, GF, VX, and VR.

60 ieved by applying novel technologies such as VR simulation to colonoscopy.

61 sualized before Calot triangle dissection at VR in 100% of cases, at NIR-C in 98.15%, and in 96.15% a

62 A dangerous variant identified at VR induced a "fundus first" approach.

63 igm in humans using a commercially available VR headset and a cross-platform game engine.

64 Integrated nerve activities and average VR were measured every 10 seconds over 24 hours.

65 Of 8 DP residents, 6 practiced 5 basic VR tasks (median 1 trial to pass), and 7 of 8 practiced

66 ty map to define genetic differences between VR-PAH and VN-PAH, we found enrichment in vascular smoot

67 -varying predictor) and the relation between VR and other clinical outcomes.

68 ies, annexin V, mutant MFG-E8 unable to bind VR, or VR antagonist).

69 SBP was reduced by calcium-channel blockers (VR 0.81, 95% CI 0.76-0.86, p<0.0001) and non-loop diuret

70 d either vincristine (R-CHOP) or bortezomib (VR-CAP).

71 of laparoscopic surgical performance on both VR and porcine LCs, although at the expense of increased

72 We aimed to prospectively evaluate NIR-C, VR-AR, and x-ray intraoperative cholangiography (IOC) du

73 H (VR-PAH) accounts for a minority of cases, VR-PAH has a pronounced response to calcium channel bloc

74 ic Analysis System for Vision Research (COAS-VR).

75 The vagal nerve that controls VR during AF may be different from that which controls s

76 Currently described VR curricula consist of trainees practicing the same tas

77 The three-dimensional VR planning enabled the identification of 12 anatomical

78 Durable VR seems to be feasible in a substantial proportion of p

79 The rates of durable VR did not significantly differ according to the VR defi

80 The pooled rates of durable VR remission were 51.4%, 39.3%, and 38.2% at 12, 24, and

81 , and is inhibited by blocking the PS/MFG-E8/VR pathway (by adding PS blocking antibodies, annexin V,

82 se strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir

83 as been developed for a modern high-fidelity VR colonoscopy simulator.

84 g, odds ratio 0.79, 0.71-0.87, p<0.0001, for VR< or =0.80), and both remained significant in a combin

85 ounds but close to the range established for VR-XnO by protein crystallography.

86 ntially different genetic predisposition for VR-PAH.

87 second-order schedule of reinforcement (FR2 [VR 16:S]).

88 o further define which patients benefit from VR.

89 Microarrays of cultured lymphocytes from VR-PAH and VN-PAH patients followed at Vanderbilt Univer

90 We review recent results from VR research in genetic model organisms where the potenti

91 We assessed the effectiveness of ToT from VR laparoscopic simulation training in 2 studies.

92 Scores for FVA, VR QoL, and HR QoL were reduced in children with glaucom

93 ationally resonant sum-frequency generation (VR-SFG) spectra, the resonant signal contains informatio

94 operative performance, compared to a generic VR warm-up or no warm-up.

95 A), sarin (GB), soman (GD), cyclosarin (GF), VR, VX, and VM adducts to tyrosine (Tyr).

96 023, and 0.083 ng/mL for GA-, GB-, GD-, GF-, VR-, and VX/VM-Tyr, respectively.

97 oup comparison revealed significantly higher VR reduction, attachment, and KT gain in group 1 than in

98 mecourse of adaption was similar in both HMD-VR and CT.

99 ealthy individuals were placed in either HMD-VR or CT and trained on an identical visuomotor adaptati

100 However, HMD-VR participants utilized a greater cognitive strategy th

101 s by which visuomotor adaption occurs in HMD-VR appear to be more reliant on cognitive strategies.

102 isms of motor learning and adaptation in HMD-VR versus a conventional training (CT) environment have

103 ween implicit and explicit mechanisms in HMD-VR versus CT.

104 ptation on a visuomotor rotation task in HMD-VR yields similar adaptation effects in CT and whether t

105 Immersive, head-mounted virtual reality (HMD-VR) provides a unique opportunity to understand how chan

106 variant H115W loses the ability to hydrolyze VR but has improved activity toward paraoxon and VX.

107 ) compared to AAV4, but at only three (VR-I, VR-II, and VR-IV) compared to AAV2 and AAV8.

108 We developed a decision tree to identify VR-PAH patients on the basis of the results with validat

109 IMG/VR has a user-friendly interface that allows users to in

110 Here we present IMG/VR, the largest publicly available database of 3908 isol

111 Exposure to an immersive VR experience also led to higher APAIS score (difference

112 OLD and FAIR MRI revealed gradually impaired VR to carbogen in HD mice.

113 The resultant impaired VR might hinder cerebral hemodynamics and increase brain

114 Optimizing ARV weighting may further improve VR predictions.

115 In VR, place cells showed robust spatial selectivity; howev

116 d, and its speed dependence was abolished in VR, but phase precession was unaffected, constraining me

117 ence of a short (ca. 2.22 A) Mo=/--S bond in VR-XnO.

118 presentations can be sufficiently engaged in VR.

119 d distance traveled were greatly enhanced in VR tasks with stereotypical trajectories.

120 e contraction-related genes were enriched in VR-PAH, suggesting a potentially different genetic predi

121 objective test for presence and fidelity in VR.

122 -core and multicore structures were found in VR.

123 Despite impaired spatial selectivity in VR, most spikes occurred within approximately 2-s-long h

124 g random foraging and goal-directed tasks in VR.

125 entially encoded distance along the track in VR, while encoding absolute position in RW.

126 substantial heterogeneity between trials in VR (p<1 x 10(-40)), 68% of which was attributable to all

127 on pathways and greater genetic variation in VR-PAH versus VN-PAH.

128 e score of the Ocular Surface Disease Index (VR-OSDI).

129 that these changes can explain the inferior VR in HD mice.

130 r GVs differ in vasodilator-responsive IPAH (VR-PAH) versus vasodilator-nonresponsive IPAH (VN-PAH).

131 ssory variability determinant (Avd ), but is VR-independent.

132 infection, we also predict population-level VR times for noncontrollers consistent with observations

133 ship between vision-related quality of life (VR QOL; Visual Activities Questionnaire [VAQ] and the 25

134 At baseline, mean VR, HR, CAL, KTW, and TT values were similar (P >0.05).

135 deo-rate structured illumination microscopy (VR-SIM) for rapid high-resolution diagnostic imaging of

136 deo-rate structured illumination microscopy (VR-SIM) of the intact removed tumor surface as a practic

137 s and on-therapy VR > 24 than </= 24 months (VR at 12 months off-NAs: 75.0% versus 35.6%, P = 0.005).

138 > 24 months offers higher chances of off-NA VR in patients with HBeAg-negative chronic hepatitis B.

139 y); mean IVI-C score, 67.3 (SD, 14.4; normal VR QoL, 96); median PedsQL self-report, 78.8 (IQR, 67.4-

140 vestibular stimuli alone and suggest a novel VR tool for studying rat navigation.

141 virtual reality head mounted display (Oculus VR).

142 Inc18-like vanA plasmids were found in 7% of VR E. faecalis isolates and none of the VR E. faecium is

143 Here, we discuss the advantages of VR and the experimental paradigms and technologies that

144 nterval condition who had the same amount of VR training distributed over 3 consecutive days.

145 ggest that the increased surface coverage of VR-SIM could also provide added value for detection and

146 we considered the highest realistic form of VR: immersive videos.

147 The frequency of VR during pancreatic surgery is increasing in the United

148 Risk factors included isolation of VR Enterococcus faecalis and use of linezolid or clindam

149 re the variables most strongly predictive of VR.

150 were the strongest independent predictors of VR.

151 A clinically relevant review of VR-SIM images of 34 unfixed and uncut prostate core biop

152 In conjunctival MLs, the use of VR with Melan-A and HMB45 provides substantial sensitivi

153 peed, minimal complexity, and ease of use of VR-SIM could prove to be features in favor of adoption a

154 orta with age, but was markedly lower in old VR (P < 0.05).

155 1) and activity (P = 0.05) were lower in old VR vs. old cage control.

156 O component in old cage control, but not old VR mice.

157 enhances the quality of performance based on VR laparoscopic cholecystectomy.

158 the same task but with 1 group pretrained on VR simulation.

159 (n = 30) were randomized to either train on VR simulation before completing an equivalent real-world

160 Training on VR simulators has been shown to improve technical perfor

161 Across all trials, effects of treatment on VR of SBP (r2=0.372, p=0.0006) and on mean SBP (r2=0.328

162 isone administered orally on days 1 to 5) or VR-CAP (R-CHOP regimen, but replacing vincristine with b

163 ents without NAT, N+ patients without NAT or VR; (2) R1-0 mm posterior-margin for the NAT group (P =

164 nexin V, mutant MFG-E8 unable to bind VR, or VR antagonist).

165 to the very rapid form of xanthine oxidase (VR-XnO) is reported.

166 Although vasodilator-responsive PAH (VR-PAH) accounts for a minority of cases, VR-PAH has a p

167 ly through a head-mounted display (panoramic VR).

168 veral key issues to consider when performing VR experiments and provide an outlook for the future of

169 signed to either the treadmill training plus VR group (n=154) or treadmill training alone group (n=14

170 icantly lower in the treadmill training plus VR group than in the treadmill training group (incident

171 icantly lower in the treadmill training plus VR group than it had been before training (6.00 [95% CI

172 high risk for falls, treadmill training plus VR led to reduced fall rates compared with treadmill tra

173 ve 6 weeks of either treadmill training plus VR or treadmill training alone.

174 lls per 6 months for treadmill training plus VR).

175 langiopancreatography, enabling preoperative VR exploration, and intraoperative augmented reality (AR

176 1 randomization to an immersive preoperative VR experience or standard preoperative experience strati

177 trated that patients exposed to preoperative VR had increased satisfaction during the surgical encoun

178 reconstitution (IR) is suggested to prevent VR.

179 For countries without high-quality VR data, we applied an exponential model to data from 20

180 For countries with high-quality VR we used the data as reported.

181 ountries (n=122,757 deaths) had high-quality VR, and modelled data were used for 129 countries.

182 ion in the pre-hypertensive SH rat - raising VR and driving vascular remodelling.

183 IAGPNA) is responsible for ventricular rate (VR) control during atrial fibrillation (AF) in ambulator

184 groups as indexed by the variability ratio (VR) and coefficient of variation ratio (CVR).

185 odels and indicated a lower Variation Ratio (VR) (8.10%) of TBA at 6 simulated levels.

186 L) of 10.47% (w/w) and a phase volume ratio (VR) of 0.7.

187 sition, tie-line length (TLL), volume ratio (VR), crude sample loading, pH and sodium chloride (NaCl)

188 rain vessel density and vascular reactivity (VR) to carbogen challenge of HD mice were monitored by 3

189 Three-dimensional virtual reality (VR) biliary anatomy models can be obtained via software

190 Virtual reality (VR) enables precise control of an animal's environment a

191 We use the fully immersive virtual reality (VR) environment CAVE (cave automatic virtual environment

192 the effect of exposure to a virtual reality (VR) environment preoperatively on patient-reported outco

193 ate VEPRs in a high quality virtual reality (VR) environment where real and virtual foreground object

194 rative performance versus a virtual reality (VR) generic CAS warm-up procedure or no preparation at a

195 To address this issue, Virtual Reality (VR) has been proposed as a potential solution.

196 Virtual reality (VR) holds great promise as a tool to study the neural ci

197 Augmented Reality (AR) and Virtual Reality (VR) in the fields of bioinformatics and cheminformatics

198 ll participants performed 5 Virtual Reality (VR) laparoscopic cholecystectomies (LC).

199 then trained on a validated virtual reality (VR) laparoscopic cholecystectomy (LC) curriculum.

200 ed condition who trained on virtual reality (VR) simulation during 1 day or Interval condition who ha

201 proficiency using either a virtual reality (VR) simulator or box trainer.

202 ed deliberate practice on a virtual reality (VR) simulator results in improved technical performance

203 users reveal that augmented virtual reality (VR) simulators have the potential and capability to be u

204 Advances in Virtual Reality (VR) technologies allow the investigation of simulated mo

205 training with non-immersive virtual reality (VR) to target both cognitive aspects of safe ambulation

206 development of a structured virtual reality (VR) training curriculum for colonoscopy using high-fidel

207 rat hippocampal activity in virtual reality (VR), where only distal visual and nonvestibular self-mot

208 exploring a two-dimensional virtual reality (VR).

209 e simulated using immersive virtual reality (VR).

210 ice, as animals performed a virtual-reality (VR) track running task.

211 ve immune response to prevent viral rebound (VR) and control infection.

212 ice or by coinjection of an MFG-E8 receptor (VR) inhibitor into the rat striatum.

213 l collecting duct by vasopressin V receptor (VR)-mediated activation of adenylyl cyclase (AC), cAMP-p

214 exposing cells and the vitronectin receptor (VR) on phagocytes.

215 e index, gingival index, vertical recession (VR), probing depth, clinical attachment level (CAL), ker

216 cal parameters including vertical recession (VR), probing depth, keratinized tissue (KT), and attachm

217 We recommend VR, which rarely requires specimen bleaching, as the sta

218 VP differs in nine variable surface regions (VR-I to -IX) compared to AAV4, but at only three (VR-I,

219 We reviewed data from vital registration (VR) and demographic and health surveys for information o

220 We used adequate vital registration (VR) data where available, and modelled cause-specific mo

221 n with acute and chronic vascular rejection (VR) of solid allografts.

222 on functional vision and on vision-related (VR) and health-related (HR) quality of life (QoL) in chi

223 o discontinued NAs in virological remission (VR) and were followed for >/=12 months thereafter.

224 lanar reformatted (MPR) and volume rendered (VR) images.

225 from a template repeat to a variable repeat (VR) accompanied by adenine-specific mutagenesis of proge

226 a template repeat (TR) to a variable repeat (VR) that results in adenine-to-random nucleotide convers

227 atment (NAT = 20%); 41 had venous resection (VR = 28%), and 70% received adjuvant chemotherapy.

228 avy petroleum systems, such as vacuum resid (VR) fractions, were characterized by the CID technology.

229 that bursting increases vascular resistance (VR) more than tonic stimulation (57.8 +/- 3.3% vs. 44.8

230 rms A-C who maintained a virologic response (VR) (HCV RNA <15 IU/mL) from weeks 4 to 22 stopped all t

231 edictive value (PV) of a virologic response (VR) by weeks 2, 4, and 12 of treatment on SVR.

232 algorithms at predicting virologic response (VR) during 734 treatment-change episodes (TCEs).

233 =99% of patients had a virological response (VR) at the end of treatment.

234 sociated with improved virological response (VR) rates to antiviral therapy and decreased progression

235 ile range: 33.4-94.7), virological response (VR; <60 IU/mL) occurred in 96 of 111 (86.5%) patients.

236 ion by assessing LVST-mediated ventral root (VR) response latencies, manipulating synaptic responses

237 s) cage control and voluntary wheel running (VR) B6D2F1 mice.

238 s of the results with validation in a second VR-PAH cohort from the University of Chicago.

239 l was analyzed with Ad Hoc imaging software (VR-RENDER), which provides a digital perfusion cartograp

240 ly undetectable during follow-up (stabilized VR).

241 Two patients with stabilized VR developed hepatocellular carcinoma and 2 with LL PV d

242 At TDF initiation, patients with stabilized VR had significantly higher nadir CD4(+) count, compared

243 ss only occurred in patients with stabilized VR.

244 infection of MARC-145 cells by PRRSV strains VR-2332 and VR-2385 also resulted in KPNA1 reduction, wh

245 study did not meet the co-primary subjective VR-OSDI measure (P = 0.7894).

246 zed tasks to be performed on the SurgicalSIM VR laparoscopic simulator (Medical Education Technologie

247 The primary outcome was sustained VR (SVR) (HCV RNA <15 IU/mL after 24 weeks of untreated

248 During a 10-session cognitive/technical VR course, medical residents were trained in CAS.

249 We hypothesized that VR-PAH has a different molecular cause from VN-PAH that

250 g and in vivo techniques, we have shown that VR depends critically on respiratory modulation and reve

251 The VR setup is validated by replicating previous results in

252 The VR system consisted of a motion-capture camera and a com

253 The VR-IV difference produces smaller three-fold protrusions

254 The VR-IV, which forms the larger outermost finger-like loop

255 In adult SH rats (n = 8), the VR response to bursting (44.6 +/- 3.9%) was not differen

256 The correlation observed between the VR and real-world task performance was r > 0.96 (Study 2

257 the VR-CAP group (hazard ratio favoring the VR-CAP group, 0.63; P<0.001), a relative improvement of

258 n the R-CHOP group versus 24.7 months in the VR-CAP group (hazard ratio favoring the VR-CAP group, 0.

259 end points were consistently improved in the VR-CAP group, including the complete response rate (42%

260 enia and thrombocytopenia were higher in the VR-CAP group.

261 samples are moved from CD(3)OD to D(2)O, the VR-SFG spectrum was found to change over time when the n

262 Water deprivation or administration of the VR agonist dDAVP did not increase urine osmolality of AC

263 % of VR E. faecalis isolates and none of the VR E. faecium isolates.

264 The onset of the VR response was also quicker for bursting stimulation (r

265 n the FLS trainer box was $11,975.00, on the VR simulator was $77,500.00, and conventional residency

266 he trainee practicing a specific task on the VR simulator.

267 pporting crystal structure findings that the VR adduct on BChE does not age.

268 id not significantly differ according to the VR definition (hepatitis B virus DNA <200, < 2000, < 20,

269 discontinue long-term NA therapy; on-therapy VR > 24 months offers higher chances of off-NA VR in pat

270 with HBeAg-negative patients and on-therapy VR > 24 than </= 24 months (VR at 12 months off-NAs: 75.

271 0, < 20,000 IU/mL) or duration of on-therapy VR in HBeAg-positive patients, but they were significant

272 being affected by the duration of on-therapy VR or consolidation therapy (>6 months in all studies).

273 to -IX) compared to AAV4, but at only three (VR-I, VR-II, and VR-IV) compared to AAV2 and AAV8.

274 This HI loop is adjacent to VR-VII, which is largest in AAV5.

275 A cost analysis of box training, VR training, and conventional residency training across

276 Of these, 412 patients (4.0%) underwent VR, with the rate increasing from 0.7% in 2000 to 6.0% i

277 udy demonstrated that patients who underwent VR during pancreatic surgery had higher rates of adverse

278 by T cells 1 (Melan-A), S100, and Ki67 using VR and a double panmelanoma cocktail (dPANMEL) using 3,3

279 se findings indicate the advantages of using VR in the experimental study of awe, with methodological

280 y), expressed as the ratio of the variances (VR), was related to effects on clinical outcomes.

281 t encoding of visual-spatial information via VR navigation task is more cerebrally challenging than r

282 o of the AAV surface variable regions (VRs), VR-IV and VR-VII.

283 % sodium citrate with a TLL of 46.38% (w/w), VR of 1.8, and 1.8% crude load at pH 7 without the prese

284 Main outcomes of interest were VR of adenovirus, EBV, human herpesvirus 6 (HHV6), cytom

285 rates were 77.6% with R-CHOP and 82.0% with VR-CHOP; they were 65.1% versus 72.4% in patients with h

286 cing (WES) on 36 patients with IPAH: 17 with VR-PAH and 19 with VN-PAH.

287 for PFS was 0.73 (90% CI, 0.43 to 1.24) with VR-CHOP ( P = .611).

288 Left VNA was associated with VR reduction during AF in 5 dogs (from 211 bpm [95% CI,

289 IVC-IAGPNA is invariably associated with VR reduction during AF.

290 IVC-IAGPNA was associated with VR reduction in all dogs studied.

291 rison, right or left VNA was associated with VR reduction only when it coactivates with the IVC-IAGPN

292 Of 734 TCEs, 475 (65%) were associated with VR.

293 fused-silica windows, were investigated with VR-SFG spectroscopy, both with and without experimental

294 ents who underwent pancreatic resection with VR were at a higher risk for intraoperative (propensity

295 tivity was best visualized in specimens with VR.

296 tients who underwent pancreatic surgery with VR had significantly higher rates of postoperative compl

297 pancreatectomy (n = 117; P = 0.049); without VR or NAT (n = 87; P = 0.003); N+ without VR or NAT (n =

298 ut VR or NAT (n = 87; P = 0.003); N+ without VR or NAT (n = 50; P = 0.004).

299 ications and mortality than patients without VR.

300 ay were similar to those of patients without VR.